RayzeBio, Inc. Common Stock (RYZB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 941.27M |
| Enterprise Value | 822.68M |
| P/E Ratio | -35.71 |
| PEG Ratio | -0.36 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -22.02 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -54.15 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.21 |
| Return On Equity | 0.83 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -67.07M |
| Net Income | -68.6M |
| Diluted EPS | -1.75 |
| Total Cash | 540.17M |
| Total Cash/Share | 7.55 |
| Total Debt | 9.72M |
| Total Debt/Equity | -0.09 |
| Current Ratio | 28.69 |
| Book Value Per Share | -2.84 |
| 52-Week Change | 160.38 |
| 52-Week High | 62.51 |
| 52-Week Low | 17.95 |
| Moving Average 50 Days | 55.78 |
| Moving Average 200 Days | 36.72 |
| Average Volume | 745,490 |
| Shares Outstanding | 60.02M |
| % Held by Institutions | 355.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |